Rajnish Wellness
BSE: RAJNISH · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Rajnish Wellness's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Rajnish Wellness is an Indian company specialising in the manufacturing and marketing of ayurvedic, herbal, and consumer healthcare products. The firm operates a diversified portfolio ranging from sexual wellness items to medicinal supplements and manages the Dava India retail pharmacy franchise network.
Business Model
The company generates revenue through the sale of consumer wellness products under brands like PlayWin and by operating a franchise-based retail pharmacy model. It leverages digital marketing and an expanding physical distribution network to reach both urban and rural markets.
Management Commentary
Management is focused on transitioning the company into an integrated wellness entity by scaling its retail footprint and diversifying into high-margin lifestyle and energy-boosting products.
Growth Outlook
Growth is driven by the expansion of the Dava India franchise network and the continuous introduction of new lifestyle wellness solutions. The company aims to capture a larger market share by strengthening its distribution reach across India.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight regarding the manufacturing and marketing of ayurvedic and medicinal products.
- Market Competition. Intense competition in the consumer healthcare and generic medicine space could pressure margins and market share.
- Franchise Operational Risk. The reliance on the Dava India franchise network introduces risks related to brand consistency and operational control across diverse locations.
Start your research today
Unlock AI insights, financials, peers and live data on Rajnish Wellness and 5,000+ companies — free.
Key Metrics
REVENUE
₹142 Cr
TTM · standalone
NET PROFIT
₹6 Cr
TTM · standalone
EPS
₹0.06
TTM · standalone
RETURN ON EQUITY
6.6%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
9.0%
TTM · standalone
P/E
6.8x
Q4 FY26 · standalone
EV/EBITDA
5.6x
Q4 FY26 · standalone
EBITDA MARGIN
5.8%
TTM · standalone
NET PROFIT MARGIN
4.6%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Rajnish WellnessRAJNISH | ₹41 Cr | 6.67 | 4.93 | 192.0% | 5.8% | 6.6% | 9.0% | -61.2% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Q4 FY26
Financials
Rajnish Wellness
BSE: RAJNISH · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Rajnish Wellness's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Rajnish Wellness is an Indian company specialising in the manufacturing and marketing of ayurvedic, herbal, and consumer healthcare products. The firm operates a diversified portfolio ranging from sexual wellness items to medicinal supplements and manages the Dava India retail pharmacy franchise network.
Business Model
The company generates revenue through the sale of consumer wellness products under brands like PlayWin and by operating a franchise-based retail pharmacy model. It leverages digital marketing and an expanding physical distribution network to reach both urban and rural markets.
Management Commentary
Management is focused on transitioning the company into an integrated wellness entity by scaling its retail footprint and diversifying into high-margin lifestyle and energy-boosting products.
Growth Outlook
Growth is driven by the expansion of the Dava India franchise network and the continuous introduction of new lifestyle wellness solutions. The company aims to capture a larger market share by strengthening its distribution reach across India.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight regarding the manufacturing and marketing of ayurvedic and medicinal products.
- Market Competition. Intense competition in the consumer healthcare and generic medicine space could pressure margins and market share.
- Franchise Operational Risk. The reliance on the Dava India franchise network introduces risks related to brand consistency and operational control across diverse locations.
Start your research today
Unlock AI insights, financials, peers and live data on Rajnish Wellness and 5,000+ companies — free.
Key Metrics
REVENUE
₹142 Cr
TTM · standalone
NET PROFIT
₹6 Cr
TTM · standalone
EPS
₹0.06
TTM · standalone
RETURN ON EQUITY
6.6%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
9.0%
TTM · standalone
P/E
6.8x
Q4 FY26 · standalone
EV/EBITDA
5.6x
Q4 FY26 · standalone
EBITDA MARGIN
5.8%
TTM · standalone
NET PROFIT MARGIN
4.6%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Pharmaceuticals
As of Q4 FY26